• -6%-6%

    EGFR-Directed Therapy in Lung Cancer

    Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) is a clinically important driver alteration affecting approximately one-third of lung cancer patients. Treatments for EGFR-exon 19 deletion and exon 21 L858R NSCLC have evolved over the last decade from first-generation reversible tyrosine kinase inhibitors (TKI) to third-generation irreversible TKIs, of which osimertinib has been […]

    ISBN: 9781009342308
    Ημ. Έκδοσης: 2023/01

    Διαθεσιμότητα: 23-28 ημέρες

    20,00€(Περιλαμβάνεται ΦΠΑ 6%)
    Καλάθι